{
  "nct_id": "NCT11879616",
  "indication": "Type 2 Diabetes",
  "phase": "Phase 2",
  "sample_size": 399,
  "duration_weeks": 55,
  "dropout_rate": 0.3,
  "primary_endpoints": [
    "Fasting plasma glucose"
  ],
  "secondary_endpoints": [
    "HbA1c reduction",
    "Fasting plasma glucose"
  ],
  "blinding": "single-blind",
  "control_arm": "placebo",
  "outcome_summary": "Study met its primary endpoint with Fasting plasma glucose showing statistically significant improvement.",
  "success": true,
  "failure_reason": ""
}